DIFFERENTIAL EFFECTS OF DESVENLAFAXINE ON HOT FLASHES IN WOMEN WITH BREAST CANCER TAKING TAMOXIFEN: A RANDOMIZED CONTROLLED TRIAL

Differential effects of desvenlafaxine on hot flashes in women with breast cancer taking tamoxifen: a randomized controlled trial

Abstract Hot flashes (HF) are a common adverse event of prolonged tamoxifen use in women with estrogen receptor-positive breast cancer, impacting psychiatric health and quality of life.While desvenlafaxine does not interact with tamoxifen, its efficacy and safety in breast cancer patients remain doctor squish refill unstudied.This phase 3, four-wee

read more